Skip to content
Axe Capital logo Axe Capital Trading News

Axon Enterprise CPO Jeffrey Kunins Sells $6 Million in Stock: Should Investors Sell Too?

2026-08-26 11:28 Josh Kohn-Lindquist The Motley Fool Positive Axe Cap view: Neutral EquitiesEarnings AXON

Axe Cap view

Axon Insider Selling Doesn’t Signal Trouble for Investors

A routine insider sale at Axon Enterprise shouldn’t spook investors given solid growth trends.

Jeffrey Kunins’ sale of $6 million worth of Axon shares might raise eyebrows, but context is key. This sale is just 5% of his holdings and follows a pre-set trading plan, meaning it’s not a knee-jerk reaction to negative news. Axon’s business remains strong, boasting 34% sales growth over nine quarters and a 44% increase in backlog. The stock’s high valuation at 80 times forward earnings explains some caution; the market prices in robust future earnings. For South African investors, Axon doesn’t map neatly onto JSE names, but its rapid growth in law enforcement tech reflects a broader trend: companies that innovate consistently tend to command premium valuations. The main risk? If Axon’s growth slows or regulatory hurdles emerge, momentum could fade. But for now, this insider sale is more routine than red flag, and selling based purely on this seems premature. this is just our opinion and not financial advice

How I would invest

Hold existing positions in growth stocks and watch for meaningful pullbacks before considering new purchases. Avoid chasing Axon currently via USD/ZAR exposure, as the high valuation leaves little margin for error.

What I would watch
  • USD/ZAR
  • AXON
What could go wrong
  • slower-than-expected growth in Axon
  • regulatory changes affecting US law enforcement tech firms
How strongly I feel

5/10

Axon Enterprise's Chief Product Officer Jeffrey Kunins sold 9,605 shares worth $6 million on August 21, 2026, under a pre-arranged Rule 10b5-1 trading plan adopted in May. The sale represents only 5% of his total holdings, and analysts view it as routine cash-raising rather than a bearish signal. Despite the stock being down 18% over the past year and trading at 80x forward earnings, Axon continues strong operational performance with 34% sales growth and a 44% backlog increase.

Our take is based on reporting first published by The Motley Fool.

Read the original story